Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innospec (IOSP) Research & Development (2016 - 2025)

Innospec's Research & Development history spans 16 years, with the latest figure at $11.0 million for Q4 2025.

  • For Q4 2025, Research & Development fell 26.17% year-over-year to $11.0 million; the TTM value through Dec 2025 reached $51.0 million, down 9.73%, while the annual FY2025 figure was $51.0 million, 9.73% down from the prior year.
  • Research & Development for Q4 2025 was $11.0 million at Innospec, down from $13.7 million in the prior quarter.
  • Across five years, Research & Development topped out at $16.2 million in Q4 2023 and bottomed at $8.4 million in Q4 2022.
  • The 5-year median for Research & Development is $10.8 million (2023), against an average of $11.6 million.
  • The largest annual shift saw Research & Development soared 92.86% in 2023 before it decreased 26.17% in 2025.
  • A 5-year view of Research & Development shows it stood at $9.5 million in 2021, then fell by 11.58% to $8.4 million in 2022, then skyrocketed by 92.86% to $16.2 million in 2023, then decreased by 8.02% to $14.9 million in 2024, then dropped by 26.17% to $11.0 million in 2025.
  • Per Business Quant, the three most recent readings for IOSP's Research & Development are $11.0 million (Q4 2025), $13.7 million (Q3 2025), and $13.6 million (Q2 2025).